Skip to main content
Article thumbnail
Location of Repository

Over expression of Plk1 does not induce cell division in rat cardiac myocytes in vitro

By Carmen H. Coxon, Katrina A. Bicknell, Fleur L. Moseley and Gavin Brooks


BACKGROUND: Mammalian cardiac myocytes withdraw from the cell cycle during post-natal development, resulting in a non-proliferating, fully differentiated adult phenotype that is unable to repair damage to the myocardium, such as occurs following a myocardial infarction. We and others previously have shown that forced expression of certain cell cycle molecules in adult cardiac myocytes can promote cell cycle progression and division in these cells. The mitotic serine/threonine kinase, Polo-like kinase-1 (Plk1), is known to phosphorylate and activate a number of mitotic targets, including Cdc2/Cyclin B1, and to promote cell division. PRINCIPAL FINDINGS: The mammalian Plk family are all differentially regulated during the development of rat cardiac myocytes, with Plk1 showing the most dramatic decrease in both mRNA, protein and activity in the adult. We determined the potential of Plk1 to induce cell cycle progression and division in cultured rat cardiac myocytes. A persistent and progressive loss of Plk1 expression was observed during myocyte development that correlated with the withdrawal of adult rat cardiac myocytes from the cell cycle. Interestingly, when Plk1 was over-expressed in cardiac myocytes by adenovirus infection, it was not able to promote cell cycle progression, as determined by cell number and percent binucleation. CONCLUSIONS: We conclude that, in contrast to Cdc2/Cyclin B1 over-expression, the forced expression of Plk1 in adult cardiac myocytes is not sufficient to induce cell division and myocardial repair

Topics: 615, 610
Publisher: Public Library of Science
Year: 2009
OAI identifier:

Suggested articles


  1. (2004). Adaptive and maladaptive hypertrophic pathways: points of convergence and divergence.
  2. (1999). Altered expression of cell cycle proteins and prolonged duration of cardiac myocyte hyperplasia in p27KIP1 knockout mice.
  3. (1999). An intrinsic timer that controls cell-cycle withdrawal in cultured cardiac myocytes.
  4. (2000). Analysis of CAK activities from human cells. doi
  5. (1998). Arresting developments in the cardiac myocyte cell cycle: role of cyclin-dependent kinase inhibitors.
  6. (1999). Association of polo-like kinase with alpha-, beta- and gamma-tubulins in a stable complex.
  7. (2007). BI 2536, a potent and selective inhibitor of polo-like kinase 1, inhibits tumor growth in vivo.
  8. (2007). Can the cardiomyocyte cell cycle be reprogrammed?
  9. (2008). Cardiomyocyte cell cycle activation improves cardiac function after myocardial infarction.
  10. (1996). Cardiomyocyte DNA synthesis and binucleation during murine development.
  11. (1998). Cell cycle profiles and expressions of p21CIP1 AND P27KIP1 during myocyte development.
  12. (1999). Cell cycle regulatory molecules (cyclins, cyclindependent kinases and cyclin-dependent kinase inhibitors) and the cardiovascular system; potential targets for therapy? doi
  13. (2001). Cell proliferation in the growing human heart: MIB-1 immunostaining in preterm and term infants at autopsy.
  14. (2006). Characterisation and regulation of E2F-6 and E2F-6b in the rat heart: a potential target for myocardial regeneration?
  15. (2006). Controversies in ventricular remodelling.
  16. (2003). Critical role of cyclin D1 nuclear import in cardiomyocyte proliferation.
  17. (2004). Cyclin A2 mediates cardiomyocyte mitosis in the postmitotic myocardium.
  18. (2005). Cyclin D2 induces proliferation of cardiac myocytes and represses hypertrophy.
  19. (1999). Cyclin-dependent kinase inhibitor expression in human heart failure. A comparison with fetal development.
  20. (2005). Cyclindependent kinase (CDK) phosphorylation destabilizes somatic Wee1 via multiple pathways.
  21. (2004). Degradation of a non-cycling mammalian polo-like kinase.
  22. (1997). Differential and dramatic changes of cyclindependent kinase activities in cardiomyocytes during the neonatal period.
  23. (2003). Differential contribution of inhibitory phosphorylation of CDC2 and CDK2 for unperturbed cell cycle control and DNA integrity checkpoints.
  24. (2005). Differential regulation of polo-like kinase
  25. (2004). Down-regulation of p27Kip1 promotes cell proliferation of rat neonatal cardiomyocytes induced by nuclear expression of cyclin D1 and CDK4. Evidence for impaired Skp2-dependent degradation of p27 in terminal differentiation.
  26. (1997). Downregulation of cyclin-dependent kinase inhibitors p21 and p27 in pressure-overload hypertrophy.
  27. (1997). Downregulation of polo-like kinase correlates with loss of proliferative ability of cardiac myocytes.
  28. (1995). Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2.
  29. (1997). Expression and activities of cyclins and cyclin-dependent kinases in developing rat ventricular myocytes.
  30. (1998). Expressions and activities of cell cycle regulatory molecules during the transition from myocyte hyperplasia to hypertrophy.
  31. (2004). Forced expression of the cyclin B1-CDC2 complex induces proliferation in adult rat cardiomyocytes.
  32. (1997). Formation of binucleated cardiac myocytes in rat heart: I. Role of actin-myosin contractile ring. doi
  33. (1997). Formation of binucleated cardiac myocytes in rat heart: II. Cytoskeletal organisation.
  34. (1984). Formation of binucleated myocardial cells in the neonatal rat. An index for growth hypertrophy.
  35. (2002). Functional studies on the role of the C-terminal domain of mammalian polo-like kinase.
  36. (2002). Genotoxic stressinduced activation of Plk3 is partly mediated by Chk2.
  37. (2002). Hershko A
  38. (1998). Histone H3 phosphorylation is required for the initiation, but not maintenance, of mammalian chromosome condensation.
  39. (1995). Identification by targeted differential display of an immediate early gene encoding a putative serine/ threonine kinase. doi
  40. (2003). Identification of a consensus motif for Plk (Polo-like kinase) phosphorylation reveals Myt1 as a Plk1 substrate.
  41. (1999). Identification of a novel phosphorylation site on histone H3 coupled with mitotic chromosome condensation.
  42. (2003). Inhibition of E2F abrogates the development of cardiac myocyte hypertrophy.
  43. (2000). Left ventricular remodeling after myocardial infarction: pathophysiology and therapy.
  44. (2003). Loss of p53 has site-specific effects on histone H3 modification, including serine 10 phosphorylation important for maintenance of ploidy.
  45. (2002). Mammalian Polo-like kinase 3 (Plk3) is a multifunctional protein involved in stress response pathways. doi
  46. (1997). Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation.
  47. (1998). Mutation of the polo-box disrupts localization and mitotic functions of the mammalian polo kinase Plk.
  48. (2005). p38 MAP kinase inhibition enables proliferation of adult mammalian cardiomyocytes.
  49. (2005). Phosphorylation of Nlp by Plk1 negatively regulates its dynein-dynactin-dependent targeting to the centrosome.
  50. (2003). Phosphorylation: polo kinase joins an elite club.
  51. (2002). Plk phosphorylation regulates the microtubule-stabilizing protein TCTP.
  52. (2002). Plk1 promotes nuclear translocation of human Cdc25C during prophase.
  53. (2001). Plk3 functionally links DNA damage to cell cycle arrest and apoptosis at least in part via the p53 pathway. doi
  54. (2005). Plk4 haploinsufficiency causes mitotic infidelity and carcinogenesis.
  55. (2007). Plk4-induced centriole biogenesis in human cells.
  56. (2001). Polo-like kinase 1 phosphorylates cyclin B1 and targets it to the nucleus during prophase.
  57. (2007). Polo-like kinase 1 triggers the initiation of cytokinesis in human cells by promoting recruitment of the RhoGEF Ect2 to the central spindle.
  58. (2001). Polo-like kinase interacts with proteasomes and regulates their activity.
  59. (2004). Polo-like kinase-1 controls recovery from a G2 DNA damage-induced arrest in mammalian cells.
  60. (2004). Polo-like kinase-2 is required for centriole duplication in mammalian cells.
  61. (2004). Polo-like kinases and the orchestration of cell division.
  62. (1998). Polo-like kinases: positive regulators of cell division from start to finish.
  63. (2003). Pololike kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation.
  64. (2006). Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage. doi
  65. (2006). Protein kinases controlling the onset of mitosis. doi
  66. (1996). Purification and molecular cloning of Plx1, a Cdc25-regulatory kinase from Xenopus egg extracts.
  67. (1996). Rapid transition of cardiac myocytes from hyperplasia to hypertrophy during postnatal development. doi
  68. (2003). Reactivation of the mitosis-promoting factor in postmitotic cardiomyocytes.
  69. (1998). Role of G1 phase cyclins and cyclindependent kinases during cardiomyocyte hypertrophic growth in rats.
  70. (2005). SAK/PLK4 is required for centriole duplication and flagella development.
  71. (2007). Stem Cell Differentiation: Cardiac Repair. Cells Tissues Organs.
  72. (2005). Structure and function of Polo-like kinases.
  73. (1993). Sugino A
  74. (2005). Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice.
  75. (1995). The conserved Schizosaccharomyces pombe kinase plo1, required to form a bipolar spindle, the actin ring, and septum, can drive septum formation in G1 and G2 cells.
  76. (2000). The Ki-67 protein: from the known and the unknown.
  77. (2003). The molecular basis for phosphodependent substrate targeting and regulation of Plks by the Polo-box domain.
  78. (2005). The Polo kinase Plk4 functions in centriole duplication.
  79. (2007). The small-molecule inhibitor BI 2536 reveals novel insights into mitotic roles of pololike kinase 1.
  80. (2005). Yeast polo-like kinases: functionally conserved multitask mitotic regulators.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.